Novel Imaging Approaches for Predicting Arrhythmic Risk

Mark I. Travin, Dali Feng, Cynthia C. Taub

Research output: Contribution to journalArticlepeer-review

17 Scopus citations


Determination of ventricular arrhythmic risk is crucial for guiding management of cardiac disease. Although for patients at increased risk an implantable cardioverter-defibrillator is recommended, it is widely acknowledged that current criteria for device use based predominantly on left ventricular ejection fraction are deficient. Genesis of ventricular arrhythmias involves a complex interaction of myocardial substrate abnormalities, precipitating triggers, and modulating factors. There are much data showing that by more directly assessing these factors, noninvasive imaging using echocardiography, radionuclide imaging, and cardiac magnetic resonance enhances arrhythmic risk stratification beyond ejection fraction and commonly used electrocardiographic and serum biomarkers. It is anticipated that further technological advancements studied in well-designed clinical trials will provide both more precise determination of risk and guide therapies to enhanced survival and patient well-being.

Original languageEnglish (US)
JournalCirculation: Cardiovascular Imaging
Issue number11
StatePublished - Nov 1 2015


  • MIBG
  • arrhythmias
  • cardiac
  • cardiac
  • death
  • defibrillators
  • echocardiography
  • implantable
  • magnetic resonance imaging
  • radionuclide imaging
  • sudden

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Novel Imaging Approaches for Predicting Arrhythmic Risk'. Together they form a unique fingerprint.

Cite this